Level as Diagnostic Biomarker of Prostate Cancer
by Syah Mirsya Warli
Submission date: 17-May-2023 02:32PM (UTC+0700) Submission ID: 2095271982
File name: 4.pdf (465.84K) Word count: 4733
Character count: 24790
1 4 11
11
4 5
8
2
7
8
9 12
12 14
16 16
2
2 3
3
4
4
10
16
%SIMILARITY INDEX
14
%INTERNET SOURCES
17
%PUBLICATIONS
7
%STUDENT PAPERS
1
3
%2
2
%3
2
%4
1
%5
1
%6
1
%7
1
%PRIMARY SOURCES
Submitted to Prairie View A&M University
Student Paper
academic.oup.com
Internet Source
uroweb.org
Internet Source
cyberleninka.org
Internet Source
www.researchsquare.com
Internet Source
wjon.org
Internet Source
Simpa S. Salami, Folke Schmidt, Bharathi
Laxman, Meredith M. Regan et al. "Combining urinary detection of TMPRSS2:ERG and PCA3 with serum PSA to predict diagnosis of
prostate cancer", Urologic Oncology:
Seminars and Original Investigations, 2013
Publication
10
1
%11
1
%12
1
%13
1
%14
1
%15
1
%16
1
%www.hindawi.com
Internet Source
repository.ubn.ru.nl
Internet Source
meridian.allenpress.com
Internet Source
www.kpventures.com
Internet Source
Allison Young, Nallasivam Palanisamy, Javed Siddiqui, David P. Wood et al. " Correlation of Urine and to ERG+ and Total Prostate Cancer Burden ", American Journal of Clinical
Pathology, 2012
Publication
Day, J.R.. "PCA3: From basic molecular science to the clinical lab", Cancer Letters, 20110201
Publication
Stephan, Carsten, Bernhard Ralla, and Klaus Jung. "Prostate-specific antigen and other
serum and urine markers in prostate cancer",
Exclude quotes Off Exclude bibliography On
Exclude matches < 1%
